Scientist Live
Exploring Science: News, Ideas & Research
Notification
Notification
Innovative Molecules adds novel EBV antiviral program to virology pipeline
The program consists of several directly acting, highly potent targeted polymerase inhibitors and is planned to advance to Phase 1 in 2027
Partnership to enhance cell therapy manufacturing
CCRM and CDMO subsidiary OmniaBio have partnered with Avectas
Partnership to advance research in rare neurodevelopmental disorders
Servier and n-Lorem Foundation join forces
Collaboration to advance innovative therapies for patients with Idiopathic Pulmonary Fibrosis
Simcere Pharmaceutical Group has entered into a research collaboration agreement with Stanford Medicine
Next-gen xDC platforms for Bispecific ADC and AOC development
Antibody engineering technology company Creative Biolabs has formed a strategic expansion of its next-generation bioconjugate (xDC) development services.
Top Stories
Editor's pick
News
Trending Posts
Welcome Back!